Corporate News 12-Sep-22
Ajanta Pharma's Dahej unit undergoes USFDA audit
Receives two observations under form 483
Ajanta Pharma announced that the company's formulation facility at Dahej was inspected by US FDA from 5 September 2022 to 9 September 2022. At the end of the inspection, Form 483 was issued to the company with 2 procedural observations.
Previous News
Ajanta Pharma
( Results - Analysis 29-Jul-22 11:30 )
Ajanta Pharma
( Results - Analysis 10-May-22 16:35 )
Ajanta Pharma
( Results - Analysis 31-Jan-22 17:21 )
Ajanta Pharma fixes record date for bonus issue
( Market Beat - Reports 13-Jun-22 13:07 )
Ajanta Pharma to conduct AGM
( Corporate News - 01-Jun-23 13:01 )
Ajanta Pharma AGM scheduled
( Corporate News - 15-Jun-24 10:25 )
Ajanta Pharma fixes record date for interim dividend
( Market Beat - Reports 22-Oct-18 18:40 )
Ajanta Pharma consolidated net profit rises 8.36% in the June 2019 quarter
( Results - Announcements 02-Aug-19 08:23 )
Ajanta Pharma to announce Quarterly Result
( Corporate News - 24-Jan-23 11:10 )
Ajanta Pharma announces board meeting date
( Corporate News - 21-Jul-21 14:04 )
Neuland Laboratories Ltd Spurts 8.97%, S&P BSE Healthcare index Rises 1.07%
( Hot Pursuit - 03-Feb-21 09:30 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
